Co-Payment Assistance Granted $46M to Prostate Cancer Patients in 2014

Co-Payment Assistance Granted $46M to Prostate Cancer Patients in 2014

The End of Prostate CancerDuring 2014, the non-profit organization The End of Prostate Cancer granted more than $46 million to 12,000 patients suffering from prostate cancer in the form of co-payment assistance and education programs being conducted in collaboration with The Patient Access Network (PAN) Foundation.

The two organizations have worked together to reduce the burden on prostate cancer patients, and have managed to expand the program for 2015, as announced in a press release.

Working in partnership since 2013, The End of Prostate Cancer and the PAN Foundation are particularly focused on offering comprehensive support to patients diagnosed with metastatic castrate resistant prostate cancer (mCRPC).  “There are more than two million prostate cancer patients in the U.S. today and too many of them are cut off from affording treatments they desperately need to fight the disease,” explained Jamie Bearse, the CEO of ZERO – The End of Prostate Cancer.

“Our partnership with the PAN Foundation helps to stop the pain and suffering due to prostate cancer by providing education and support to thousands of patients with advanced disease,” Bearse added. The co-payment program is the result of a union of the already existing financial assistance program from the PAN Foundation with the educational resources for both patients and healthcare professionals provided by The End of Prostate Cancer.

“Especially with the growth of high-deductible, high-copay health insurance plans, prostate cancer patients are facing greater challenges than ever affording their prescribed medications. Working together, the PAN Foundation and ZERO offer essential financial assistance and support services to these patients,” stated the president and CEO of the PAN Foundation, Daniel Klein.

Additionally, the two organizations have also announced they are expanding the program in order to reach patients with non-metastatic advanced prostate cancer and plan to support more men and families. Patients who want to know if they are eligible for the co-payment assistance can get additional information at the website of ZERO – The End of Prostate Cancer.

The national nonprofit organization ZERO – The End of Prostate Cancer has been dedicated to end prostate cancer by supporting research and education, while the independent national organization PAN Foundation has been focused on offering co-payment assistance to underinsured patients through 60 disease-specific programs.